サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


The Global Bioinformatics Market: Market size, forecasts and company profiles

世界のバイオインフォマティクス市場:市場規模、予測、企業概要

レポート概要

バイオインフォマティクス・ツールはほとんどが創薬の分野で使用され、生体分子構造の分析、視覚化のためのデータ収集、編成に役立ちます。臨床試験の分野において薬剤の安全性に対する重要性が高まり、規制が強化されている中で、製薬企業は医薬品開発を成功させるために効果的な技術を導入する必要に迫られています。研究対象医薬品の数が増加し、新薬開発技術が導入された結果、データが無限に増殖しています。バイオインフォマティクスはデータを効果的に視覚化することによって創薬のプロセスにおける時間とコストの削減に有用です。

バイオインフォマティクス企業はアウトプットの品質を向上させる必要に迫られたことから、がんなどの疾患への応用のための強化ツールの創生に取り組むようになり、また個別化医療の重要性が高まったことが薬理ゲノム学研究の推進につながりました。その結果、特に分子医療の分野においてより効果的、画期的なバイオインフォマティクス・ツールが開発されました。このレポートはバイオインフォマティクス市場をレベルごと、つまりツール、サービス、コンテンツ/データベース、アプリケーション、地域別に分類し、2014年までの市場を予測しています。市場の推進要因、阻害要因の分析のほか、バイオインフォマティクスのその他の応用例について解説します。そのほか、最近の合併、連携、製品の発売状況など、バイオインフォマティクス企業55社の概要も掲載しています。

レポート詳細

目次

Table of Contents

Executive summary
Market overview
Competitive landscape & market dynamics
The bioinformatics tools market
The bioinformatics
The bioinformatics service market
The bioinformatics
Regional analysis of the bioinformatics
Company profiles
Chapter 1 Market overview
Summary
Introduction
Defining the bioinformatics market
Market evolution increases use of bioinformatics
Bioinformatics and drug development
Sequencing tools are high priority
Bioinformatics database management tools
Bioinformatics patent analysis
Genomics remains the key segment
High market presence of Japanese market players
Bioinformatics service outsourcing shifting to Asian markets
Market Size
Chapter 2 Competitive landscape & market dynamics
Summary
Introduction
Competitive landscape
Recent mergers and acquisitions
Recent product, technology and service launches
Market drivers
Need for integrated data-handling tools for drug discovery
Growth in genomics and proteomics industry
Wide applications in drug discovery and development
Government support for R&D
Biomarker discovery enables the development of safe drugs
Developments in internet and IT
Emergence of high-throughput screening
Other drivers
Resistors of market growth
Common, well-defined data formats are needed
Need for trained resources compound operational costs
Saturation of pharmaceutical markets reduces adoption rate
Restricted range of product/service offerings
Other restraints to market growth
Growth opportunities
Pressure to escalate drug research productivity
Drug development value chain to widen opportunities
High market demand for integrated systems and solutions
Chemogenomics poses vast opportunity for growth
Applications in diversified areas to expand the user base
Data overload in the field of research
Chapter 3 The bioinformatics tools market
Summary
Introduction
Growth drivers
Need for better output quality in drug discovery
Integration of bioinformatics resources
Application of bioinformatic tools in the life sciences market
Resistors of growth
Complex operations of bioinformatic tools restricts growth
High price of analytical solutions may not be feasible
Sequence analysis tools
DNA sequence analysis tools
Sequence alignment
Gene detection
Restriction, and repeats and unusual patterns detection
Transcriptional elements detection
tRNA detection
Protein function assignment
Protein-protein interaction
Pattern, motif, profiles, domains and families search
Search, computation and analysis of pathways
Protein annotation
Automatic alerts for related new sequences
3D structure analysis and modeling tools
3D viewers
3D homology modeling
3D analysis
RNA analysis tool
Microarray data analysis
Phylogenetic analysis
Multiple sequence alignment
Organism classification
Sequence alignment tools
Sequence analysis (alignment)
Multiple sequence alignment
Phylogenetic tree building
Consensus sequence and translation
Lab end-sequence analysis
Primer design
Cloning
Contig assembly
Sequence manipulation tools
Sequence analysis (including sequence manipulation)
Sequence manipulation
Format conversion
Random sequences
Structural analysis tools
Sequence visualization tools
3D protein structure
Dot plots
Graphical and phylogenetic tree viewers and editors
Primary sequence analysis
Physicochemical property alignment
Alignment tools
Predicting secondary structure sequences
Other bioinformatics tools
Visualization tools
Database viewers
Sequence viewers
Molecular viewers
Physical mapping software
Chapter 4 The bioinforma content/database market
Summary
Introduction
Growth drivers
Exponential growth in the proteomics data and databases
Data integration devices needed for in-house solutions
Growth in the clinical trials industry supports the market
Specialized databases
Specialized sequence databases
Genome databases
Collections
Model organism databases
Specialized protein databases
Proteome databases
Protein classification databases
Specific protein family databases
Specialized structural databases
Microarray databases
Pathways databases
2D-PAGE databases
General databases
Primary sequence databases
Protein sequence databases
3D structure databases
Carbohydrate databases
Chapter 5 The bioinformatics services market
Summary
Introduction
Growth drivers
Growing trend towards consultancy
Requirement for highly efficient data-mining tools
Need for total integration & warehousing solutions
Data analysis services
Genomics data analysis
Proteomics data analysis
Microarray data analysis
Modeling & computational bioinformatics services
Sequencing services
High-throughput screening
Multiple sequence alignment
Resequencing (SNP profiling)
Primer walking
Expression profile clustering
Shotgun sequencing
Database management services
Conception and realization
Development of user interface
Maintenance
Backup systems
Migration
Other services
Security systems
Data-mining services
Infrastructure integration services
Knowledge management
Chapter 6 The bioinformatics applications market
Summary
Introduction
Global market dynamics
Growth drivers
Rapid development of molecular diagnostics market
Development in personalized medicine
Specific medicines developed to treat the source of disease
Resistors of growth
Need for more holistic solutions
Bioinformatics considered to be for specialized applications only
Opportunities
Application in the military
Bioinformatics in epidemiology
Integration of systems biology with bioinformatics
Molecular medicine
Global market
US
Europe
Asia
Preventive medicine
Gene therapy
Growth drivers
Biomarker discovery helps gene therapy to determine disease
candidates
Demand for gene therapy treatment necessitates bioinformatics
application
Opportunities
Data proliferation in the field of gene therapy
Declining growth of gene therapy market
Drug development
Growth drivers
Drastic cost reduction in the process of drug discovery
Data processing needs in the drug development process
Virtual high-throughput screening
Sequence analysis
Similarity searches
Drug lead optimization
Physicochemical modeling
Drug bioavailability and bioactivity
Other applications
Chapter 7 Regional analysis of the bioinformatics market
Summary
Introduction
North America
Europe
Asia
India and China
The Indian bioinformatics industry
Business opportunities in India and China
Growth drivers
Growth resistors
Rest of the World
Chapter 8 Company profiles
Summary
3rd Millennium Inc.
Company overview
Products and services
Company strategy
Accelrys, Inc.
Company overview
Products and services
Company strategy
Affymetrix
Company overview
Products and services
Company strategy
Agilent Technologies, Inc.
Company overview
Products and services
Company strategy
Animech Technologies AB
Company overview
Products and services
Company strategy
Bruker Daltonics inc.
Company overview
Products and services
Company strategy
Ariadne Genomics
Company overview
Products and services
Company strategy
Biobase GmbH
Company overview
Products and services
Company strategy
BioDiscovery, Inc.
Company overview
Products and services
Company strategy
Bioinformatics Solutions Inc.
Company overview
Products and services
Company strategy
Biomatters Ltd
Company overview
Products and services
Company strategy
Biomax Informatics AG
Company overview
Products and services
Company strategy
BioWisdom Ltd
Company overview
Products and services
Company strategy
Celera Genomics Corporation
Company overview
Products and services
Company strategy
CLC bio
Company overview
Products and services
Company strategy
Geospiza, Inc.
Company overview
Products and services
Company strategy
Clontech Laboratories, Inc.
Company overview
Products and services
Company strategy
Definiens AG
Company overview
Products and services
Company strategy
DNASTAR, INC.
Company overview
Products and services
Company strategy
Expression Analysis, Inc.
Company overview
Products and services
Company strategy
Gene Logic
Company overview
Products and services
Company strategy
Genedata AG
Company overview
Products and services
Company strategy
GeneGo
Company overview
Products and services
Company strategy
Geneva Bioinformatics SA
Company overview
Products and services
Company strategy
Genologics Life Sciences Software
Company overview
Products and services
Company strategy
Genomatix Software Inc
Company overview
Products and services
Company strategy
GenomeQuest, Inc
Company overview
Products and services
Company strategy
Helicos Biosciences Corporation
Company overview
Products and services
Company strategy
Illumina Inc.
Company overview
Products and services
Company strategy
InforMax Inc.
Company overview
Products and services
Company strategy
Nucleics Pvt Ltd
Company overview
Products and services
Company strategy
Inforsense Limited
Company overview
Products and services
Company strategy
Kinexus Bioinformatics Corporation
Company overview
Products and services
Company strategy
MDS Inc.
Company overview
Products and services
Company strategy
Miraibio Group
Company overview
Products and services
Company strategy
Golden Helix, Inc
Company overview
Products and services
Company strategy
Invitrogen Corporation
Company overview
Products and services
Company strategy
Molegro
Company overview
Products and services
Company strategy
Nonlinear Dynamics
Company overview
Products and services
Company strategy
Textco Biosoftware, Inc.
Company overview
Products and services
Company strategy
Numerical Algorithms Group Ltd
Company overview
Products and services
Company strategy
Ocimum Biosolutions Ltd.
Company overview
Products and services
Company strategy
Partek Inc.
Company overview
Products and services
Company strategy
Phase Forward Inc.
Company overview
Products and services
Company strategy
Premier Biosoft International
Company overview
Products and services
Company strategy
Protein Forest Inc.
Company overview
Products and services
Company strategy
Rosetta Biosoftware
Company overview
Products and services
Company strategy
Silicon Graphics Inc.
Company overview
Products and services
Company strategy
Softberry Inc.
Company overview
Products and services
Company strategy
Softgenetics, LLC.
Company overview
Products and services
Company strategy
Strand Life Sciences
Company overview
Products and services
Company strategy
Synamatix Sdn Bhd
Company overview
Products and services
Company strategy
Teranode Corporation
Company overview
Products and services
Company strategy
Tibco Spotfire
Company overview
Products and services
Company strategy
Tripos International
Company overview
Products and services
Company strategy
Chapter 9 Appendix
Index

List of Figures
Figure 1.1: Bioinformatics components
Figure 1.2: Bioinformatics market segmentation
Figure 1.3: Market transition impacting bioinformatics market
Figure 1.4: Role of bioinformatics in drug development process
Figure 1.5: Comparative analysis of the bioinformatics application market
Figure 1.6: Relative importance of bioinformatic tool features (2009 vs 2014)
Figure 1.7: Market size versus growth in the bioinformatic tools market
Figure 1.8: Market size versus growth in the bioinformatic services market
Figure 1.9: Patents approved by technology (%), 2004 vs 2008
Figure 1.10: Patents approved by company, 2004-08
Figure 1.11: Regional approval of patents, 2004 vs 2008
Figure 2.12: Strategic focus of bioinformatics companies, 2008-09
Figure 3.13: Bioinformatic tools market dynamics
Figure 3.14: Level of market attractiveness of bioinformatic tools
Figure 3.15: Sequence analysis process and application of bioinformatic tools
Figure 4.16: Bioinformatics content/database market dynamics
Figure 5.17: Bioinformatics services market dynamics
Figure 5.18: Level of attractiveness of the bioinformatics services market
Figure 6.19: Regional distribution of bioinformatics applications market, 2009 and 2014
Figure 6.20: Global scenario for molecular medicine
Figure 6.21: Level of market attractiveness for other bioinformatic applications
Figure 7.22: Market revenues for Asia, 2008 vs 2014
Figure 7.23: Comparative impact of business environment (India and China), 2009
Figure 7.24: Indian bioinformatics market structure
Figure 7.25: Source of revenue for Indian bioinformatics firms
Figure 7.26: Major opportunities for Indian IT market players
Figure 7.27: Business opportunities in India and China
Figure 7.28: Key trends impacting India and China

List of Tables
Table 1.1: Global bioinformatics market by submarket, 2007-14($m)
Table 2.2: Recent mergers and acquisitions, 2008-09
Table 2.3: New product, technology or service launches, 2008-09
Table 2.4: New product, technology or service launches, 2008-09 (contd 1)
Table 2.5: New product, technology or service launches, 2008-09 (contd 2)
Table 2.6: New product, technology or service launches, 2008-09 (contd 3)
Table 3.7: Global bioinformatic tools market by product, 2007-14 ($m)
Table 3.8: Bioinformatic tools market by region, 2007-14 ($m)
Table 3.9: Global sequence analysis tools market by product function,
Table 3.10: Sequence analysis tools market by region, 2007-14 ($m)
Table 3.11: Global DNA sequence analysis tools market by product function, 2007-14 ($m)
Table 3.12: DNA sequence analysis tools market by region, 2007-14 ($m)
Table 3.13: Sequence alignment market by region, 2007-14 ($m)
Table 3.14: Gene detection market by region, 2007-14 ($m)
Table 3.15: Market for restriction and detection of repeats and unusual patterns by region, 2007-14 ($m)
Table 3.16: Transcriptional elements detection market by region, 2007-14 ($m)
Table 3.17: tRNA detection market by region, 2007-14 ($m)
Table 3.18: Global protein function assignment market by product function, 2007-14 ($m)
Table 3.19: Protein function assignment market by region, 2007-14 ($m)
Table 3.20: Protein-protein interactions tools market by region, 2007-14 ($m)
Table 3.21: Market for pattern, motif, profiles, domains and families search by region, 2007-($m)
Table 3.22: Search, computation and analysis of pathways market by region, 2007-14 ($m)
Table 3.23: Protein annotation market by region, 2007-14 ($m)
Table 3.24: Automatic alerts for related new sequences market by region, 2007-14 ($m)
Table 3.25: Global 3D structure analysis and modeling market by product function, 2007-14 ($m)
Table 3.26: 3D structure analysis and modeling market by region, 2007-14 ($m)
Table 3.27: 3D viewers market by region, 2007-14 ($m)
Table 3.28: 3D homology modeling market by region, 2007-14 ($m)
Table 3.29: 3D analysis market by region, 2007-14 ($m)
Table 3.30: RNA analysis tool market by region, 2007-14 ($m)
Table 3.31: Microarray data analysis market by region, 2007-14 ($m)
Table 3.32: Global phylogenetic analysis market by product function, 2007-14 ($m)
Table 3.33: Phylogenetic analysis market by region, 2007-14 ($m)
Table 3.34: Multiple sequence alignment market by region, 2007-14 ($m)
Table 3.35: Organism classification market by region, 2007-14 ($m)
Table 3.36: Sequence alignment tools market by product function, 2007-14 ($m)
Table 3.37: Sequence alignment tools market by region, 2007-14 ($m)
Table 3.38: Sequence analysis (alignment) tools market by product function, 2007-14 ($m)
Table 3.39: Sequence analysis (alignment) tools market by region, 2007-14 ($m)
Table 3.40: Multiple sequence alignment market by region, 2007-14 ($m)
Table 3.41: Phylogenetic tree building market by region, 2007-14 ($m)
Table 3.42: Consensus sequence and translation by region, 2007-14 ($m)
Table 3.43: Lab end-sequence analysis market by product function, 2007-14 ($m)
Table 3.44: Lab end-sequence analysis by region, 2007-14 ($m)
Table 3.45: Primer design market by region, 2007-14 ($m)
Table 3.46: Cloning market by region, 2007-14 ($m)
Table 3.47: Contig assembly market by region, 2007-14 ($m)
Table 3.48: Sequence manipulation tools market by product function, 2007-14 ($m)
Table 3.49: Sequence manipulation tools market by region, 2007-14 ($m)
Table 3.50: Sequence analysis (including sequence manipulation) market by region, 2007-14 ($m)
Table 3.51: Sequence manipulation market by region, 2007-14 ($m)
Table 3.52: Format conversion market by region, 2007-14 ($m)
Table 3.53: Random sequences market by region, 2007-14 ($m)
Table 3.54: Global structural analysis tools market by product function, 2007-14 ($m)
Table 3.55: Structural analysis tools market by region, 2007-14 ($m)
Table 3.56: Global sequence visualization market by product, 2007-14 ($m)
Table 3.57: Sequence visualization market by region, 2007-14 ($m)
Table 3.58: 3D protein structure market by region, 2007-14 ($m)
Table 3.59: Dot plots and others market by region, 2007-14 ($m)
Table 3.60: Graphical and phylogenetic tree viewer and editor market by region, 2007-14 ($m)
Table 3.61: Primary sequence analysis market by region, 2007-14 ($m)
Table 3.62: Physicochemical property alignment market by region, 2007-14 ($m)
Table 3.63: Alignment tools market by region, 2007-14 ($m)
Table 3.64: Tools to predict secondary structure sequence market by region, 2007-14 ($m)
Table 3.65: Global other tools market by product, 2007-14 ($m)
Table 3.66: Other tools market by region, 2007-14 ($m)
Table 3.67: Visualization tools market by product, 2007-14 ($m)
Table 3.68: Visualization tools market by region, 2007-14 ($m)
Table 3.69: Database viewers market by region, 2007-14 ($m)
Table 3.70: Sequence viewers market by region, 2007-14 ($m)
Table 3.71: Molecular viewers market by region, 2007-14 ($m)
Table 3.72: Physical mapping software market by region, 2007-14 ($m)
Table 4.73: Global content/database market by product, 2007-14 ($m)
Table 4.74: Content/database market by region, 2007-14 ($m)
Table 4.75: Global specialized database market by product, 2007-14 ($m)
Table 4.76: Specialized database market by region, 2007-14 ($m)
Table 4.77: Specialized sequence databases market by region, 2007-14 ($m)
Table 4.78: Global genome databases market by product, 2007-14 ($m)
Table 4.79: Genome databases market by region, 2007-14 ($m)
Table 4.80: Collections market by region, 2007-14 ($m)
Table 4.81: Model organism databases market by region, 2007-14 ($m)
Table 4.82: Global specialized protein databases market by product, 2007-14 ($m)
Table 4.83: Specialized protein databases market by region,
Table 4.84: Proteome databases market by region, 2007-14 ($m)
Table 4.85: Protein classification databases market by region, 2007-14 ($m)
Table 4.86: Specific protein family databases market by region, 2007-14 ($m)
Table 4.87: Specialized structural databases market by region, 2007-14 ($m)
Table 4.88: Microarray databases market by region, 2007-14 ($m)
Table 4.89: Pathway databases market by region, 2007-14 ($m)
Table 4.90: 2D-PAGE databases market by region, 2007-14 ($m)
Table 4.91: Global general database market by product, 2007-14 ($m)
Table 4.92: General database market by region, 2007-14 ($m)
Table 4.93: Primary sequence databases market by region, 2007-14 ($m)
Table 4.94: Protein sequence databases market by region, 2007-14 ($m)
Table 4.95: 3D structure databases market by region, 2007-14 ($m)
Table 4.96: Carbohydrate databases market by region, 2007-14 ($m)
Table 5.97: Global services market by product function, 2007-14 ($m)
Table 5.98: Services market by region, 2007-14 ($m)
Table 5.99: Global data analysis services market by product function, 2007-14 ($m)
Table 5.100: Data analysis services market by region, 2007-14 ($m)
Table 5.101: Genomics data analysis market services by region, 2007-14 ($m)
Table 5.102: Proteomics data analysis services market by region, 2007-14 ($m)
Table 5.103: Microarray data analysis services market by region, 2007-14 ($m)
Table 5.104: Modeling & computational bioinformatics services market by region, 2007-14 ($m)
Table 5.105: Global sequencing services market by product function, 2007-14 ($m)
Table 5.106: Sequencing services market by region, 2007-14 ($m)
Table 5.107: High-throughput sequencing market by region, 2007-14 ($m)
Table 5.108: Multiple sequence alignment market by region, 2007-14 ($m)
Table 5.109: Resequencing services market by region, 2007-14 ($m)
Table 5.110: Primer walking market by region, 2007-14 ($m)
Table 5.111: Expression profile clustering and sequence pattern market by region, 2007-14 ($m)
Table 5.112: Shotgun sequencing (bacterial artificial chromosomes and cosmids) market by region,2007-14 ($m)
Table 5.113: Global database management market by product function, 2007-14 ($m)
Table 5.114: Database management market by region, 2007-14 ($m)
Table 5.115: Conception and realization market by region, 2007-14 ($m)
Table 5.116: User interface development market by region, 2007-14 ($m)
Table 5.117: Maintenance market by region, 2007-14 ($m)
Table 5.118: Backup system market by region, 2007-14 ($m)
Table 5.119: Migration market by region, 2007-14 ($m)
Table 5.120: Other services market by region, 2007-14 ($m)
Table 5.121: Other services market by region, 2007-14 ($m)
Table 5.122: Security system market by region, 2007-14 ($m)
Table 5.123: Data-mining services by region, 2007-14 ($m)
Table 5.124: Infrastructure integration services market by region, 2007-14 ($m)
Table 5.125: Knowledge management market by region, 2007-14 ($m)
Table 6.126: Global applications market by product segment, 2007-14 ($m)
Table 6.127: Global molecular medicine market by product segment, 2007-14 ($m)
Table 6.128: Global preventive medicine market by product segment, 2007-14 ($m)
Table 6.129: Global gene therapy market by product segment, 2007-14 ($m)
Table 6.130: Global drug development market by product function, 2007-14 ($m)
Table 6.131: Global other applications market by product function, 2007-14 ($m)
Table 7.132: Market forecast for bioinformatics by region, 2007-14 ($m)
Table 7.133: North American bioinformatics market, 2007-14 ($m)
Table 7.134: European bioinformatics market, 2007-14 ($m)
Table 7.135: Asian bioinformatics market, 2007-14 ($m)
Table 7.136: RoW bioinformatics market, 2007-14 ($m)
Table 9.137: US bioinformatics patents
Table 9.138: US bioinformatics patents (contd 1)
Table 9.139: US bioinformatics patents (contd 2)
Table 9.140: US bioinformatics patents (contd 3)
Table 9.141: European bioinformatics patents
Table 9.142: European bioinformatics patents (contd 1)
Table 9.143: European bioinformatics patents (contd 2)
Table 9.144: Japanese bioinformatics patents
Table 9.145: Japanese bioinformatics patents (contd 1)
Table 9.146: Japanese bioinformatics patents (contd 2)

発刊日

2009/09/01

体裁

PDF / 265ページ

販売価格

3,835USD

発行

Business Insights Ltd.

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます

関連カテゴリ

創薬一般

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE